Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hidradenitis Suppurativa

• Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
• A Phase 1 Study of LT-002-158 Intended for the Treatment of Skind Disorder in Healthy Adult Volunteers
• Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
• A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
• A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
• Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).
• Hidradenitis Suppurativa Study of Izokibep
• A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
• A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa
• Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients
• Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
• Efficacy of Laser Hair Removal Therapy in HS
• Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa
• A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
• A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
• Fractional CO2 Laser Fenestration and Steroid Delivery in HS Lesions
• Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients
• Hidradenitis Suppurativa Phase 2b Pivotal Study of Izokibep
• A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
• Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa
• A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.
• ATI-450 vs Placebo in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
• A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy
• Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
• Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
• Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa
• Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa
• Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa
• A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
• Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa
• Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa
• A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
• A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
• A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)
• A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
• LTX-109 as Treatment for Hidradenitis Suppurativa
• Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa
• Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa
• A Study of LY3041658 in Adults With Hidradenitis Suppurativa
• To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
• A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms
• Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
• Gentian Violet Treatment for Hidradenitis Suppurativa
• An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab
• Tofacitinib for Immune Skin Conditions in Down Syndrome
• A Study to Test the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
• Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
• Hidradenitis Suppurativa Patient Experience With Humira Treatment
• Spironolactone for Hidradenitis Suppurativa
• A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
• Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.
• A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa
• Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
• Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab
• Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa
• A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
• Treatment of Moderate Hidradenitis Suppurativa
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)
• Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa
• Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
• This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
• A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
• A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
• A Study of Bermekimab in Patients With Hidradenitis Suppurativa
• Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
• Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
• A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.
• Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS
• Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
• Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis
• Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
• Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically
• Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa
• A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.
• Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa
• MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB
• Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients
• An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.
• A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa
• Anakinra in Hidradenitis Suppurativa
• Anakinra as a Treatment for Hydradenitis Suppurativa
• Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
• Treatment of Hidradenitis Suppurativa Using Etanercept
• Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
• To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
• Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa
• A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
• Etanercept in Hidradenitis Suppurativa
• Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa
• Etanercept for Treatment of Hidradenitis